Emtricitabine Dimer Impurity, with the CAS number 1962114-97-1, is a chemical compound that is recognized as an impurity associated with the antiretroviral drug emtricitabine, which is used in the treatment of HIV. This dimeric form arises from the dimerization of emtricitabine molecules, typically under specific conditions during synthesis or storage. The compound is characterized by its structural features, which include the presence of two emtricitabine units linked together, potentially affecting its pharmacological properties and stability. As an impurity, it is important to monitor its levels in pharmaceutical formulations to ensure safety and efficacy. The presence of such impurities can influence the overall quality of the drug product, necessitating rigorous analytical methods for detection and quantification. Understanding the characteristics of Emtricitabine Dimer Impurity is crucial for pharmaceutical development and regulatory compliance, ensuring that the final product meets the required standards for therapeutic use.

Emtricitabine Dimer Impurity

1962114-97-1: Emtricitabine Dimer Impurity, with the CAS number 1962114-97-1, is a chemical compound that is recognized as an impurity associated with the antiretroviral drug emtricitabine, which is used in the treatment of HIV. This dimeric form arises from the dimerization of emtricitabine molecules, typically under specific conditions during synthesis or storage. The compound is characterized by its structural features, which include the presence of two emtricitabine units linked together, potentially affecting its pharmacological properties and stability. As an impurity, it is important to monitor its levels in pharmaceutical formulations to ensure safety and efficacy. The presence of such impurities can influence the overall quality of the drug product, necessitating rigorous analytical methods for detection and quantification. Understanding the characteristics of Emtricitabine Dimer Impurity is crucial for pharmaceutical development and regulatory compliance, ensuring that the final product meets the required standards for therapeutic use.

CAS 1962114-97-1

Emtricitabine Dimer Impurity

Emtricitabine Impurity 50

Ref: 4Z-E-5813

Emtricitabine Dimer Impurity

Ref: ST-EA-CP-E5042